載入...

Ceramide-tamoxifen regimen targets bioenergetic elements in acute myelogenous leukemia(1)

The objective of our study was to determine the mechanism of action of the short-chain ceramide analog, C6-ceramide, and the breast cancer drug, tamoxifen, which we show coactively depress viability and induce apoptosis in human acute myelogenous leukemia cells. Exposure to the C6-ceramide-tamoxifen...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Lipid Res
Main Authors: Morad, Samy A. F., Ryan, Terence E., Neufer, P. Darrell, Zeczycki, Tonya N., Davis, Traci S., MacDougall, Matthew R., Fox, Todd E., Tan, Su-Fern, Feith, David J., Loughran, Thomas P., Kester, Mark, Claxton, David F., Barth, Brian M., Deering, Tye G., Cabot, Myles C.
格式: Artigo
語言:Inglês
出版: The American Society for Biochemistry and Molecular Biology 2016
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4918852/
https://ncbi.nlm.nih.gov/pubmed/27140664
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1194/jlr.M067389
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!